Тема: Разработка ПЦР-системы для определения уровней экспрессии интерферонов мыши

Ank, N., West, H., and Paludan, D.S.R. (2006). IFN-λ: Novel Antiviral Cytokines. J.
Interferon Cytokine Res. 379, 373–379.
Barton, K., Muthusamy, N., Chanyangam, M., Fischer, C., Clendenin, C., and Leiden,
J.M. (1996). Defective thymocyte proliferation and IL-2 production in transgenic mice
expressing a dominant-negative form of CREB. Nature 379, 81–85.
Boehm, U., Klamp, T., Groot, M., and Howard, J.C. (1997). Cellular responses to
interferon-gamma . Annu. Rev. Immunol. 15, 749–795.
Bouma, G., and Strober, W. (2003). The immunological and genetic basis of
inflammatory bowel disease. Nat. Rev. Immunol. 3, 521–533.
Castranova, V., Asgharian, B., Sayre, P., Virginia, W., and Carolina, N. (2016).
Interferons and viruses an evolutionary arms race of molecular. 36, 1922–2013.
Coccia, E.M., Severa, M., Giacomini, E., Monneron, D., Remoli, M.E., Julkunen, I.,
Cella, M., Lande, R., and Uzé, G. (2004). Viral infection and Toll-like receptor agonists induce a
differential expression of type I and lambda interferons in human plasmacytoid and monocytederived dendritic cells. Eur. J. Immunol. 34, 796–805.
Cohen, B., Novick, D., Barak, S., and Rubinstein, M. (1995). Ligand-induced association
of the type I interferon receptor components. Mol. Cell. Biol. 15, 4208–4214.
Der, S.D., Zhou, A., Williams, B.R.G., and Silverman, R.H. (1998). Identification of
genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.
Proc. Natl. Acad. Sci. 95, 15623–15628.
Easlick, J., Szubin, R., Lantz, S., Baumgarth, N., and Abel, K. (2010). The early
interferon alpha subtype response in infant macaques infected orally with SIV. J. Acquir.
Immune Defic. Syndr. 55, 14–28.
Fasler-Kan, E., Pansky, A., Wiederkehr, M., Battegay, M., and Heim, M.H. (1998).
Interferon-alpha activates signal transducers and activators of transcription 5 and 6 in Daudi
cells. Eur J Biochem 254, 514–519.
Filipe-Santos, O., Bustamante, J., Chapgier, A., Vogt, G., de Beaucoudrey, L., Feinberg,
J., Jouanguy, E., Boisson-Dupuis, S., Fieschi, C., Picard, C., et al. (2006). Inborn errors of IL-
12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin.
Immunol. 18, 347–361.
García-Sastre, A. (2011). Induction and evasion of type I interferon responses by
influenza viruses. Virus Res. 162, 12–18.
González-Navajas, J.M., Lee, J., David, M., and Raz, E. (2012). Immunomodulatory
functions of type i interferons. Nat. Rev. Immunol. 12, 125–135.
Grogan, J.L., and Locksley, R.M. (2002). T helper cell differentiation: On again, off
again. Curr. Opin. Immunol. 14, 366–372.
Hillyer, P., Mane, V.P., Schramm, L.M., Puig, M., Verthelyi, D., Chen, A., Zhao, Z.,
Navarro, M.B., Kirschman, K.D., Bykadi, S., et al. (2012). Expression profiles of human42
interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent. Immunol. Cell
Biol. 90, 774–783.
Hiscott, J., Nguyen, T.L.A., Arguello, M., Nakhaei, P., and Paz, S. (2006). Manipulation
of the nuclear factor-κB pathway and the innate immune response by viruses. Oncogene 25,
6844–6867.
Horvath, C.M. (2004). The Jak-STAT pathway stimulated by interferon gamma. Sci.
STKE 2004, tr8.
Hu, X., and Ivashkiv, L.B. (2009). Cross-regulation of Signaling Pathways by Interferon-
γ: Implications for Immune Responses and Autoimmune Diseases. Immunity 31, 539–550.
Ivashkiv, L.B., and Donlin, L.T. (2013). Regulation of type I interferon responses. Nat.
Rev. Immunol. 14, 36–49.
Iversen, M.B., Ank, N., Melchjorsen, J., and Paludan, S.R. (2010). Expression of Type III
Interferon (IFN) in the Vaginal Mucosa Is Mediated Primarily by Dendritic Cells and Displays
Stronger Dependence on NF- B than Type I IFNs. J. Virol. 84, 4579–4586.
Kawai, T., Sato, S., Ishii, K.J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K.,
Matsuda, M., Inoue, J.I., Uematsu, S., et al. (2004). Interferon-α induction through Toll-like
receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5, 1061–
1068.
Kotenko, S. V., and Donnelly, R.P. (2006). Type III Interferons: The Interferon-λ Family.
In The Interferons: Characterization and Application, pp. 141–163.
Kuo, C.T., and Leiden, J.M. (1999). Transcriptional regulation of T lymphocyte
development and function. Annu. Rev. Immunol. 17, 149–187.
Lazear, H.M., Nice, T.J., and Diamond, M.S. (2015). Interferon-λ: Immune Functions at
Barrier Surfaces and Beyond. Immunity 43, 15–28.
Li, M., Liu, X., Zhou, Y., and Su, S.B. (2009). Interferon- s: the modulators of antivirus,
antitumor, and immune responses. J. Leukoc. Biol. 86, 23–32.
Lieberman, L.A., Banica, M., Reiner, S.L., and Hunter, C.A. (2004). STAT1 Plays a
Critical Role in the Regulation of Antimicrobial Effector Mechanisms, but Not in the
Development of Th1-Type Responses during Toxoplasmosis. J. Immunol. 172, 457–463.
Liu, L., Botos, I., Wang, Y., Leonard, J.N., Shiloach, J., Segal, D.M., and Davies, D.R.
(2008). Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 320,
379–381.
Murphy, K., and Weaver, C. (2017). JANEWAY.
Negishi, H., Taniguchi, T., and Yanai, H. (2017). The Interferon (IFN) Class of
Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor Family. Cold Spring Harb.
Perspect. Biol. a028423.
Nolan, T., Hands, R.E., and Bustin, S.A. (2006). Quantification of mRNA using real-time
RT-PCR. Nat. Protoc. 1, 1559–1582.
Osterlund, P.I., Pietilä, T.E., Veckman, V., Kotenko, S. V, and Julkunen, I. (2007). IFN
regulatory factor family members differentially regulate the expression of type III IFN (IFN43
lambda) genes. J. Immunol. 179, 3434–3442.
Pearce, E.L., Mullen, A.C., Martins, G.A., Krawczyk, C.M., Hutchins, A.S., Zediak,
V.P., Banica, M., DiCioccio, C.B., Gross, D.A., Mao, C., et al. (2003). Control of Effector CD8+
T Cell Function by the Transcription Factor Eomesodermin. Science (80-. ). 302, 1041 LP-1043.
Penix, L.A., Sweetser, M.T., Weaver, W.M., Hoeffler, J.P., Kerppola, T.K., and Wilson,
C.B. (1996). The proximal regulatory element of the interferon-gamma promoter mediates
selective expression in T cells. J Biol Chem 271, 31964–31972.
Pestka, S. (2007). The interferons: 50 Years after their discovery, there is much more to
learn. J. Biol. Chem. 282, 20047–20051.
Piehler, J., Thomas, C., Christopher Garcia, K., and Schreiber, G. (2012). Structural and
dynamic determinants of type I interferon receptor assembly and their functional interpretation.
Immunol. Rev. 250, 317–334.
Poynter, S.J., and DeWitte-Orr, S.J. (2016). Fish interferon-stimulated genes: The
antiviral effectors. Dev. Comp. Immunol. 65, 218–225.
Rosenzweig, S.D., and Holland, S.M. (2005). Defects in the interferon-gamma and
interleukin-12 pathways. Immunol. Rev. 203, 38–47.
Sada-Ovalle, I., Chiba, A., Gonzales, A., Brenner, M.B., and Behar, S.M. (2008). Innate
invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce
interferon-γ, and kill intracellular bacteria. PLoS Pathog. 4.
Sadler, A.J., and Williams, B.R.G. (2008). Interferon-inducible antiviral effectors. Nat.
Rev. Immunol. 8, 559–568.
Schoenborn, J.R., and Wilson, C.B. (2007). Regulation of interferon-gamma during
innate and adaptive immune responses. Adv. Immunol. 96, 41–101.
Skurkovich, B., and Skurkovich, S. (2003). Anti-interferon-gamma antibodies in the
treatment of autoimmune diseases. Curr. Opin. Mol. Ther. 5, 52–57.
Szubin, R., Chang, W.L.W., Greasby, T., Beckett, L., and Baumgarth, N. (2008). Rigid
interferon-alpha subtype responses of human plasmacytoid dendritic cells. J. Interferon Cytokine
Res. 28, 749–763.
Takeuchi, O., and Akira, S. (2010). Pattern Recognition Receptors and Inflammation.
Cell 140, 805–820.
Thomas, C., Moraga, I., Levin, D., Krutzik, P.O., Podoplelova, Y., Trejo, A., Lee, C.,
Yarden, G., Vleck, S.E., Glenn, J.S., et al. (2011). Structural linkage between ligand
discrimination and receptor activation by Type i interferons. Cell 146, 621–632.
Ullah, M.O., Sweet, M.J., Mansell, A., Kellie, S., and Kobe, B. (2016). TRIF-dependent
TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic
target. J. Leukoc. Biol. 100, 27–45.
Woelk, C.H., Frost, S.D.W., Richman, D.D., Prentice, E., and Pond, S.L.K. (2008).
Evolution of the interferon alpha gene family in eutherian mammals. Gene 397, 38–50.
Zhang, X., Brann, T.W., Zhou, M., Yang, J., Oguariri, R.M., Lidie, K.B., Imamichi, H.,
Huang, D.-W., Lempicki, R.A., Baseler, M.W., et al. (2011). Cutting Edge: Ku70 Is a Novel44
Cytosolic DNA Sensor That Induces Type III Rather Than Type I IFN. J. Immunol. 186, 4541–
4545.
Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M.J., and Kroemer, G. (2015). Type I
interferons in anticancer immunity. Nat. Rev. Immunol. 15, 405–414.
Ершов.Ф.И. (2012). Интерферон.
Купить